ASP Isotopes Inc. Common Stock

Day range

$1.99 – $2.19

Open

$2.09

Prev close

$1.95

Volume

3.85M

Market cap

$298.19M

Shares out

153.31M

P/E

—

P/S

9.69

P/B

1.13

P/FCF

—

ROE

-49.9%

ROA

-23.1%

Debt/Equity

1.00

Div yield

0.00%

As of Oct 23, 2026

• Joint venture agreementOct 15, 2026

  The Agreement establishes a binding commercial framework for a joint venture between QLE and Necsa (the "Joint Venture") to develop, finance, construct, commission, own, and operate a test bench and commercial-scale facility for the production of High-Assay Low-Enriched Uranium ("HALEU") at Necsa's Pelindaba site in South Africa.

• Merger agreementOct 2, 2026

  As previously disclosed, on June 25, 2026, ASP Isotopes Inc. ... entered into an Agreement and Plan of Merger ... pursuant to which ... Merger Sub will merge with and into Noble Africa ... with Noble Africa surviving the Merger as a direct wholly-owned subsidiary of ENDRA.

• Investor presentationSep 8, 2026

  On September 8, 2026, ASP Isotopes Inc. issued a press release announcing that the Company is hosting its inaugural Capital Markets Day today in London. In addition, the Company released its Capital Markets Day presentation, which is available on the Company's website, on the Investor Relations page under News and Events.

• Credit facilityAug 20, 2026

  On August 14, 2026, Renergen Limited (the "Borrower"), a wholly-owned subsidiary of ASP Isotopes Inc. (the "Company"), entered into a Second Amendment and Restatement Agreement (the "Second Amendment") with The Standard Bank of South Africa Limited (the "Lender"). The Second Amendment provides for a secured ZAR term loan facility in an aggregate principal amount equal to ZAR230,532,658.90 (or approximately USD14,212,864.30 using a current exchange rate) (the "Commitment" or the "Loan").

• Product or service launchAug 20, 2026

  Tetra4 Proprietary Limited, a subsidiary of Renergen Limited, has entered the commissioning phase of the Company's liquid helium plant. This represents a significant operational milestone for the Company's product offering in the helium production sector.

Days to cover

5.3

Short interest

26.46M

Avg volume

4.98M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock
  neutralGlobeNewswire Inc.· Jul 15, 2026
• Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
  negativeGlobeNewswire Inc.· Mar 20, 2026
• Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf
  negativeGlobeNewswire Inc.· Mar 18, 2026
• Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); EOS Energy Enterprise, Inc. (NASDAQ: EOSE); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
  negativeGlobeNewswire Inc.· Mar 14, 2026
• Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform
  positiveBenzinga· Feb 24, 2026